While several studies have consistently shown that plasma VWF levels are extremely high and result in an elevated VWF/ADAMTS13 ratio in severe COVID-19, to the best of our knowledge, this is the first study to systematically assess VWF in tissue samples from patients who died of COVID-19 in comparison to well-matched controls. This evidence concerns the gene ADAMTS13 and COVID-19.